Guía detallada disponible en inglés. MFMD ofrece orientación y coordinación del centro en español.
There is not one universal onsite schedule for every non-AHCA hormone practice. Appropriate onsite involvement depends on the clinic structure, services, procedures, staffing, medication handling, and applicable framework. MFMD uses a hybrid model — it does not use a remote-only model.
Abrir la explicación completa3 secciones y fuentes primarias
Why does an initial in-person review help in HRT and TRT?
An in-person start lets the physician understand patient flow, medication storage, controlled-substance handling, injection workflow, pellet-procedure space (if applicable), provider/staff roles, escalation, and documentation — which matters more when a Schedule III controlled substance is involved.
How is ongoing governance handled after the initial visit?
Ongoing governance can be remote when appropriate, with onsite involvement when the clinic, services, or circumstances require it. For AHCA clinics, Medical Director pre-survey readiness stays focused on the physician-governance role rather than replacing the clinic’s AHCA consultant.
Owner takeaway
Remote governance can be useful, but the Medical Director should know the physical practice and be able to become onsite when it matters.